IGALMI

BioXcel Therapeutics, Inc.

Application Filed: 2024-06-26
Trademark Application Details
Trademark Logo IGALMI

Mark For: IGALMI™ trademark registration is intended to cover the categories of pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression.

Status

2024-07-09 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number98620766
Mark Literal ElementsIGALMI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationNot Found 2024-06-27
BasisNo
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameBrendan J. Hughes
Attorney Docket Number332712.temp

Timeline

2024-06-26Application Filed
2024-06-26Location:
2024-06-26Status: Live/Pending
2024-06-26Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2024-06-26Transaction Date
2024-06-27Location: Not Found

Trademark Parties (Applicants & Owners)

Party: BioXcel Therapeutics, Inc.
Address555 Long Wharf Drive, 12th Floor New Haven, CONNECTICUT UNITED STATES 06511
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2024-06-26
Drawing2024-06-26

Attorney of Record

Brendan J. Hughes Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
Washington, DC 20004
United States

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2024-06-26
NEW APPLICATION ENTERED2024-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed